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As a United Nations member state, South Africa is signatory to the Millennium 
Declaration and is committed to achieve the Millennium Development Goals 
(MDGs) and targets for 2015. This chapter provides an overview of the status of 
South Africa’s response to MDG 6 with a specific focus on the progress made to date 
with respect to HIV and tuberculosis (TB) – two intertwined epidemics contributing 
disproportionately to morbidity and premature mortality in South Africa. These 
epidemics are also closely linked to MDG 4 and 5 outcomes. Any progress made 
by South Africa to reverse current trends will have substantial implications for the 
global MDG targets as well as country level outcomes. This chapter will use avail-
able evidence to document the status of HIV and TB in South Africa relative to the 
South African Ministry of Health’s strategy to address these diseases.
Given the intertwined 
TB and HIV epidemics, 
integration of HIV and 
TB services is critical, 
as well as HIV testing 
of TB patients and 
early initiation on 
ART. The government 
policy on initiation of 
ARV treatment in TB 
patients at a higher 
CD4 count level is 
important, given the 
high mortality rates 
in TB-HIV co-infected 
patients ...
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Introduction
The focus of this chapter is Millennium Development Goal 
(MDG) 6, which aims to combat HIV, AIDS, tuberculosis (TB), 
malaria and cholera in order to halt and begin to reverse their 
spread. Given the limited availability of routinely collected 
data on cholera and malaria to monitor impact and temporal 
trends, these two diseases are not covered in this chapter as 
they do not make as substantial a contribution to morbidity 
and mortality rates in South Africa as do HIV and TB. South 
Africa is at the epicentre of the HIV pandemic and, as the 
epidemic has matured, the numbers with advancing HIV-
related diseases have grown. TB is the most common oppor-
tunistic infection intertwining the HIV and TB epidemics and 
exacerbating an already severe existing TB epidemic. 
Globally, two important targets were set for MDG 6: 
by 2010 to achieve universal access to treatment for HIV 
and AIDS for all those who need it; and 
by 2015 to halt and begin to reverse the incidence of 
major diseases such as HIV, TB and malaria. 
The HIV and AIDS and STI Strategic Plan (NSP) for South 
Africa, 2007-2011 has similar goals which are set to achieve 
the following: 
50% reduction in HIV incidence rates; and 
80% treatment coverage of those in need of HIV 
treatment.1
The targets for the South African Tuberculosis Strategic Plan 
for 2007-2011 are as follows:2 
70% TB case detection rate;
85% TB cure rate; and 
>85% TB treatment success rate 
Key tools required in monitoring progress include: 
the availability of robust baseline information on these 
targets;
establishing priorities and timelines for achieving the goals; 
and 
regular monitoring of progress and appropriate interven-
tions if targets are not being met. 
Very limited routine surveillance data is available to monitor 
progress on targets, or at the programmatic level, to iden-
tify bottlenecks for service delivery and coverage nationally, 
provincially or at a clinic level. Limited discussion occurs at 
the level of service delivery to set targets and timelines. This 
disconnect between policies, implementation and evalua-
tion is a critical shortcoming in the planning process and a 
major obstacle to achieving goals. There is growing recog-











cannot be resolved through adopting a standard generic 
approach. Instead, interventions need to be based on local 
knowledge and responses customised to suit local conditions. 
Interventions must include creating co-ownership through 
engaging stakeholders, through supporting staff and through 
mobilising communities to increase awareness to ensure 
adequate coverage and to monitor progress. 
The Motlanthe and Zuma administrations have demonstrated 
unequivocal leadership, substantial resource allocation, and 
clear goals and priorities to address the twin challenges of TB 
and HIV.3
HIV and AIDS
What is needed to meet the NSP goals? 
In this, the third decade of the pandemic, UNAIDS recom-
mends “know your epidemic, and customise your response 
accordingly”.4,5 This entails harvesting knowledge on preva-
lence, incidence rates, most at risk populations and factors 
contributing to the spread of HIV. Strong health information 
systems as well as local and national surveillance are critical to 
generate this information. 
In terms of available prevention interventions, the “ABC 
approach” viz. Abstinence, Behaviour change/ Be faithful and 
use of male and female Condoms remains the foundation of 
HIV prevention. Two additional Cs have been added to this – 
knowledge of HIV status through Counselling and HIV testing 
as well as medical male Circumcision. There are clear limi-
tations for women who are unable to negotiate faithfulness 
or condom use.6 The results of the CAPRISA 004 tenofovir 
gel trial, demonstrating a 39% reduction in HIV infection and 
51% reduction in genital herpes, provides hope for women-
initiated HIV prevention methods.7,8 Confirmation of the 
results, to allow licensing of the product, is necessary before 
it can become available for use. 
South Africa has one of the largest antiretroviral therapy 
(ART) programmes in the world but questions remain about 
whether it is reaching the levels of coverage needed to see 
population level reversals in morbidity and mortality trends.9 
A key gateway to prevention and treatment services is know-
ledge of HIV status: this remains low in South Africa and is 
the rationale for the South African government’s national HIV 
counselling and testing (HCT) campaign.10,11 
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Figure 1:  Prevalence of HIV infection among pregnant women attending public sector health care facilities in South Africa 
The HIV epidemic in South Africa
About five million of approximately 50 million South Africans 
are currently living with HIV, accounting for 35% of the global 
burden of HIV infection.12 An estimated 281 400 AIDS related 
deaths, and 410 000 new HIV infections occurred in 2010.12 
The South African HIV epidemic is described as a “general-
ised, hyper-endemic epidemic”, to demonstrate the unprec-
edented high HIV prevalence rate and continued rates of new 
HIV infections.4,13 Despite HIV being rare prior to 1990, the 
epidemic has evolved rapidly to an unprecedentedly high HIV 
prevalence, in excess of 15% for people aged between 15 
to 49 years.10,14,15 New infection rates are more than 5% per 
year,16-19 with high and increasing morbidity and mortality 
rates.13,20-24 The high HIV prevalence places all sexually active 
persons at substantial risk of acquiring HIV infection. The 
majority of the new HIV infections are taking place in young 
adults under the age of 30, with young women under the age 
of 20 having three to six-fold higher rates of HIV infection 
compared to their male counterparts in this age group. 
The predominant mode of HIV transmission in South Africa 
is through heterosexual sex, accounting for about 80% of all 
HIV infections, and by mother-to-child transmission.10,13 The 
major drivers of HIV include: social incohesion resulting from 
the migrant labour system;25-27 “no sense of future” resulting 
from high unemployment rates; low perceptions of self-risk; 
multiple concurrent sexual partnerships; poor internalisation 
of HIV statistics and its implications for HIV risk; high preva-
lence and incidence rates of HIV; peer pressure for young 
people to be sexually active; lack of knowledge of HIV status; 
gender and power disparities that restrict young women’s 
ability to negotiate monogamy or condom use; and high 
burden of other sexually transmitted diseases.25-29 
HIV prevalence 
The National Antenatal Sentinel HIV and Syphilis Prevalence 
(ANC) surveys undertaken from 1990 provide the most reli-
able data to understand the evolving HIV epidemic in South 
Africa.30 The temporal trends in national distribution of HIV 
infection from 1990 to 2009 are presented in Figure 1. 
These surveys demonstrate that the HIV epidemic in South 
Africa peaked in the late 1990s and has now reached a stable 
state.13,30 This stabilisation of HIV prevalence suggests a steady 
state between the number of new HIV infections and numbers 
of deaths in this population. The data also demonstrate that 
the epidemic is most advanced in KwaZulu-Natal. In the 2008 
survey, the highest HIV prevalence of 38.7% among pregnant 
women attending public sector clinics was in KwaZulu-Natal, 
and lowest in the Western Cape Province at 16.1%.30
An analysis of the ANC survey data by age (Table 1) demon-
strates that young pregnant women in the 15-24 year age group 
continue to have a high HIV prevalence. As HIV prevalence in 
this age group is regarded as a proxy of incidence rates, this 
is of concern.31 Whilst there has been a slight decline in the 
HIV prevalence in the 15-19 year age group from 15.9% in 
2005 to 13.7% in 2009, the prevalence remains high. By age 
30 years, more than a third of pregnant women nationally are 
already infected with HIV, highlighting the enormous burden 
of infection in young pregnant women. This burden in young 
women is higher and is reached earlier in life on the east coast 
of South Africa. 
source: Department of Health, 2009.
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15-19 15.9 13.7 13.1 14.1 13.7
20-24 30.6 28.0 28.0 26.9 26.6
25-29 39.5 38.7 37.5 37.9 37.1
30-34 36.4 37.0 39.6 40.0 41.5
35-39 28.0 29.3 33.0 32.4 35.4
≥40 19.8 18.4 21.4 20.5 24.8
Total 30.2 29.1 29.4 29.3 29.4
source: Department of Health, 2007; 2010.30,32
HIV prevalence trends in pregnant women may not be repre-
sentative of trends in all women. In the context of a maturing 
epidemic fertility rates decline in HIV-positive women, thus 
decreasing the reliability of the ANC data in terms of moni-
toring the evolving epidemic.33,34 Notwithstanding these limi-
tations, the antenatal HIV surveillance of pregnant women 
remains an important source of data to monitor trends in HIV 
prevalence in the general population. Additionally, as preven-
tion of mother-to-child transmission (PMTCT) services are 
strengthened, the ANC surveys provide one way to track the 
coverage and quality of services provided and to strengthen 
routine data collection at the point of service delivery. This can 
be used to enhance localised understanding of the epidemic 
and inform priority setting. It also provides an opportunity to 
link efforts to achieve MDGs 4 and 5. 
It should be noted that as AIDS deaths lag behind new infec-
tions, HIV prevalence data in mature epidemics mask the 
ongoing increase of new HIV infections.31 Increasing access to 
ART and increased survival will also increase HIV prevalence. 
It is therefore important to augment HIV prevalence data 
derived from ANC surveys with data from other sources, 
including HIV incidence rate data. This is in order to get a 
more accurate indication of trends of HIV infection, guide 
HIV prevention efforts and planning for health care delivery. 
Measuring new HIV infections for sub-populations, such as 
young women in the 15-19 year age group, and acquiring 
knowledge of factors associated with HIV acquisition, are 
more sensitive ways to monitor HIV trends and target inter-
ventions for greater efficiency and impact but are expensive 
and logistically complicated to undertake. Given the close link 
between advancing HIV-related disease and TB, expanding 
surveillance to include TB populations is one way of moni-
toring trends in the HIV epidemic.35 
Population-based surveys generate important data by geog-
raphy, age, sex and race and provide valuable information to 
supplement an understanding of the HIV epidemic in South 
Africa. The Human Sciences Research Council (HSRC) has 
undertaken three national HIV household surveys (HSRC 
Household Survey) in 2002, 2005 and 2008.10,14,15 These 
surveys demonstrate that HIV prevalence in the general 
population in the 15-49 years age group increased from 
15.6% in 2002, to 16.2% in 2005 and to 16.9% in 2008. 
The HIV prevalence among young men and women in the 
15-24 year age group increased from 9.3% in 2002 to 10.3% 
in 2005, and decreased to 8.7% in 2008. A distinctive char-
acteristic of the HIV epidemic is the age and sex difference 
in distribution of HIV infection, with young women acquiring 
HIV infection approximately five to seven years earlier than 
men. Age of partner is a key risk factor in HIV acquisition in 
young women under 20 years and this increases substantially 
if the male partner is four or more years older than the female 
partner.10,28 
HIV incidence rates
Monitoring changes in the rate of new HIV infections is critical 
to understanding the changing HIV transmission dynamics. 
National and provincial HIV incidence rates in South Africa 
have been generated from several studies and are presented 
in Table 2. 
HIV incidence rates remain high.19,36 To estimate the HIV inci-
dence from cross-sectional studies, the HIV-1 subtypes B, E, 
and D IgG-capture enzyme immunoassay (BED-CEIA) used 
in the 2005 HSRC Household Survey showed an overall HIV 
incidence rate of 1.4% per year amongst persons 2 years and 
older, and 2.4% among men and women aged 15-48 years. 
Young women in the age group 20-29 years had the highest 
rate of 5.6% compared to 0.9% amongst men in the same 
age group.17 Between 2003 and 2005, a prospective popula-
tion based study conducted in rural KwaZulu-Natal showed 
the adjusted HIV incidence rate to be 7.9 per 100 person 
years for women 15-49 years of age, and 5.9 per 100 person 
years for men 15-54 years of age, confirming a high rate of 
new HIV infections.37 However, modelling the HIV incidence 
estimate from HSRC surveys has shown an overall decline in 
HIV incidence rates from 2% per year in 2005 to 1.3% per 
year in 2008.38 
Amongst non-pregnant women, HIV incidence rates have 
exceeded 5 per 100 person years in both urban and rural 
settings, with the highest rate of 17.2 per 100 person years 
recorded in young urban women 14-19 years of age, though 
this estimate may be biased due to the small sample size.16,19,39,40 
Among high risk women the HIV incidence rate was 7.2 per 
100 person years, while in the Western Cape amongst 16-20 
year old participants in a vaccine preparedness study the HIV 
incidence rate was 9.2 per 100 person years.18,41 
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Government’s response to HIV 
and AIDS
A key response to HIV and AIDS is President Zuma’s 
announcement on World AIDS Day in 2009 in which the 
following prevention initiatives were prioritised: 
Information, education and mass mobilisation;
STI detection and management;
HIV testing and counselling to know one’s status;





Medical male circumcision; and 
Strengthening co-operation with international partners. 
At the core of this plan lies the implementation of an exten-
sive social mobilisation campaign to promote knowledge 
of HIV status. The national launch of the HCT campaign 
occurred on Sunday, 25 April 2010 at Natalspruit Hospital 











“I am Responsible, We are Responsible, South Africa is taking 
Responsibility”, the HCT Campaign seeks to achieve the 
following broad objectives: 
mobilise people to know their status; 
support people with key prevention messages in order to 
encourage them to take proactive steps towards a healthy 
lifestyle – irrespective of HIV status; 
increase the incidence of health seeking behaviour; and 
increase access to treatment, care and support services.
The NSP provides government departments, development 
partners and all sectors of civil society with information 
regarding policy, implementing interventions, monitoring and 
evaluation and surveillance as shown in Table 3. This does not, 
however, necessarily translate into effective service delivery 
on the ground, or the uptake and consistent uptake of treat-
ment by patients. 
Several other commitments and initiatives have been made in 
South Africa that impact on mitigating the effect of HIV, AIDS 
and TB. These include the following: 
The conditional HIV and AIDS grant in the national health 
budget has increased from R4.3 billion in 2008 to an esti-






Table 2: National and provincial HIV incidence rates in South Africa
Reference Sample Method HIV incidence
National
Rehle et al., 201038 Population based surveys Modeling from 
prevalence
2005 2008
Overall National 2.0 1.3
Women (15-24 years) 5.5 2.2
Men (15-24 years) 0.5 0.8
Rehle et al., 200717 Population based survey BED-HIV-1 
capture enzyme 
immunoassay
Overall National  
(2 yrs and older)
1.4% per year
KwaZulu-Natal 1.7% per year
Women 20-29 years 5.6% per year 
Men 20-29 years 0.9% per year 
Provincial 






Kharsany et al., 201042 Rural pregnant women 11.2% per year
Ramjee et al., 200816 Rural general population, Hlabisa, 
KwaZulu-Natal (women)
Longitudinal 
studies 6.0 per 100 person years
Urban general population, 
KwaZulu-Natal (women) 5.0 per 100 person years
Abdool Karim et al., 201019 Rural family planning clinic, 
KwaZulu-Natal (women) 6.5 per 100 person years
Urban sexually transmitted disease 
clinic, KwaZulu-Natal (women) 6.4 per 100 person years
van Loggerenberg et al., 200818 Urban sex workers (women) 7.2 per 100 person years
Barnighausen et al., 200837 Population based survey, Hlabisa, 
KwaZulu-Natal
Follow-up survey Men 5.1 per 100 person years
Women 7.9 per 100 person years
Moodley et al., 200943 Urban and rural pregnant women 
KwaZulu-Natal, Eastern Cape, 
Mpumalanga public sector clinics
Retesting Overall 10.7 per 100 person years
Urban 12.4 per 100 person years
Rural 9.1 per 100 person years
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Table 3: Current status and progress on HIV prevention and treatment in relation to the NSP, 2007-2011
NSP Target Progress Current status in achievements
Improvement of 
blood and blood 
product safety
100% of donated blood units are screened for HIV.44 100% of blood donations are screened using nucleic acid amplifica-
tion testing. 
Decline in HIV transmission through blood from an average of 2 







Training of nurses at all primary health care (PHC) 
facilities to implement integrated services for PMTCT. 
Dual therapy has been introduced to almost 98% 
of health facilities through the intensified National 
PMTCT Accelerated Plan in 2008/09.44 
89% of all first time ANC clients are tested for HIV.
Target of 95% has not been achieved, resulting in 25 848 new infec-









Exposure to South Africa’s HIV prevention 
communication through media campaigns is high, 
targeting 15-24 year olds for intensive HIV prevention 
programmes.44
80% of sample surveyed had HIV prevention knowledge.44
Exposure of media campaigns to population aged 50 and older still 
remains low.44 
Knowledge about HIV prevention improved with an increase in house-




Life skills HIV 
education 
Full integration of the HIV based Life Skills 
programme in all learning areas has been achieved.44 
Inconsistencies in the delivery of programmes.ÿ
Condom provision Approximately 400 million male condoms are 
distributed annually with 2.5 billion male condoms 
expected to be distributed in 2010.44
Male and female condom distribution at no cost has been extended to 
truck stop clinics and to high transmission areas such as correctional 
service centres, tertiary institutions, hostels, taxi ranks and through 
mobile units targeting farming areas.
Condom use has increased sharply in males and females from 2005 to 
2008, especially among females with multiple partners where use has 
increased from 52.5% in 2005 to 67.5% in 2008.44
The proportion of adults reporting condom use during the most recent 
episode of sexual intercourse in South Africa increased from 31.3% in 
2002 to 64.8% in 2008.47
A major challenge has been the consistency in the maintenance of 









The prevalence of syphilis has shown a steady 
decline from 1997 (11.2%) to 1.9% in 2008.44 
Decline in syphilis rates attributed to more effective syndromic STI 
management, and possible shift in behaviour from HIV prevention 
messages.
Effective syndromic management of STIs available through PHC 
facilities.
Effective treatment rate of partners remains low. STI partner-tracing 
rate was 21% compared to the target of 40%.48
Ongoing training of health care personnel is required for sustained 
care and management of STIs. 
Community information and education on STI health seeking behav-








HCT, a key prevention strategy, serves as an 
entry point for HIV care and treatment services.44 
Government health care facilities offering HCTs 
increased from 88% in 2005-06 to 96% currently. 
The number of sexually active population tested rose 
from 25% in 2008 to 37% in 2009.47 
Delivery of HCT has been faced with several challenges of staff short-
ages, space and budget constraints.
Recent legislation, which will expand testing to trained health care 
workers, is expected to provide wider coverage in achieving the goals 
of HCT. 
Only 8% of the population are tested for HIV every year when 25% 







The South African government has adopted MMC 
as a HIV prevention tool, and rollout has started in 
pilot sites.
Voluntary MMC programme launched in April 2010 in KwaZulu-Natal.
Start of the voluntary MMC programme on 13 June 2010 at Eshowe 
Further Education and Training College with 202 initiates circumcised 
without any post operative complications. 
Voluntary MMC is expected to be rolled out throughout the country 
by 2011. 
Targets for MMC in KwaZulu-Natal are 186 703 by June 2011 with 







The NSP target is to initiate 1.5 million people on 
lifelong ART treatment by 2011. The percentage 
of adults and children with advanced HIV infection 
receiving ART has increased. 
In 2010, 490 PHC facilities were accredited to provide ART.
The government aims to increase these to 4 300 by 2011.49 
The treatment gap between those in need of ART and those taking up 
treatment remains high (Figure 2). 
The largest number of people who are in need of and not receiving 
treatment are in KwaZulu-Natal compared to the Western and Northern 
Cape (Figure 3), e.g. the province of KwaZulu-Natal has an HIV preva-
lence of 38.7% among public sector pregnant women in contrast to the 
Western Cape which has a prevalence 16.1%, yet the ART coverage 
in the Western Cape exceeds 74% compared to 43% ART coverage 
in KwaZulu-Natal.44
Despite the roll-out of ART, adequate coverage levels are yet to be 
achieved to alter current epidemic trajectories. 
The current ART programme has not been adequately evaluated and 









Health care workers have a low but measurable risk 
of HIV infection after accidental exposure to infected 
blood or body fluid.
Prevention strategies include post-exposure prophylaxis with ART 
available in all health care settings.
Poor recording and reporting of PEP coverage for rape victims.
ÿ
ÿ
a Personal Communication: S Dhlomo, July 29, 2010.
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The National Department of Health TB Programme data 
showed an increase in TB HIV co-infected patients that 
received treatment for TB and HIV from 18% in 2008 to 
42% in 2009. In 2008/09, 45% of HIV-positive patients 
were screened for TB, against the NSP target of 60%. 
Additionally, 3% of HIV-positive patients were put on 
isoniazid preventive treatment. 
The number of people living with HIV receiving nutritional 
support has increased to 734 900 for 2008/9, exceeding 
the NSP target of 500 000. 
The Social Relief of Distress budget was increased from 
R124 million to R624 million to alleviate poverty. Child 
support grants, foster care grants and care dependency 
grants all increased by an average of approximately 6% in 
2009. Seventy-five per cent of orphaned and vulnerable 
children receive support. 
Antiretroviral treatment provision 
The key target in mitigating morbidity, mortality and other 
impacts of HIV and AIDS articulated in the NSP, is providing an 
appropriate package of treatment, care and support services 
of people living with HIV and their families. To achieve this, 




Figure 2:  Distribution of number of people needing and receiving ART in South Africa 
source:  StatsSA 2009; 2010.12,50
enroll 75% of eligible patients into HIV wellness pro- 
grammes;
increase the proportion of eligible adults receiving cotri-
moxazole by 80%; and 
increase the number of new adults starting ART to 1.375 
million and children to 114 000, representing a potential 
coverage of 80% of new AIDS cases. 
Estimates from Statistics South Africa (StatsSA) are that 
approximately 920 000 patients have currently been initiated 
on ART, representing 60% coverage of adults and 38% of the 
eligible paediatric population.12
Recently published outcomes data collected from eight 
ART public sector programmes across South Africa, which 
analysed data from 2002-2007, demonstrated a decrease in 
twelve-month mortality from 9% to 6% over five years, but 
an increase in the cumulative loss to follow-up from 14% at 
12 months to 29% at 36 months. This highlights the need to 
improve strategies to monitor patient outcomes and maximise 
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Figure 3: Provincial distribution of number of people needing and receiving ART in 2008 
Tuberculosis
South Africa is estimated to have the fifth highest burden 
of TB disease in the world, which is further complicated by 
high HIV co-infection rates and a growing epidemic of drug 
resistant TB (Table 4). 
The inception of the Revised National Tuberculosis Pro-
gramme in 1996 enhanced the case detection rate for new 
smear positive TB cases over 10 fold, from 6.7% in 1997 
to 78% in 2007. However the TB treatment success rate 
increased minimally from 63% in 2000 to 71% in 2005, 
well below the national target rate of 85%.2 In 2005, South 
Africa declared a TB emergency and developed a TB Crisis 
Management Plan. The aim of this Plan was to prioritise the 
four districts with the highest TB burden and poor treatment 
outcomes (Johannesburg Metro, eThekwini District, Amathole 
and Nelson Mandela Metro) and, within one year, to increase 
smear conversion and cure rates by more than 10%. This is in 
source: StatsSA, 2009;12 2010;50 Nathea 2008.51
Table 4:  Global estimate of epidemiological burden of TB in the top five countries, 2007
Incidence Prevalence Mortality



























1. India 1 169 016 1 962 168 3 305 283 302 26 30 2.5 5.3
2. China 1 328 630 1 306 98 2 582 194 194 15 6.8 0.5 1.9
3. Indonesia 231 627 528 228 566 244 86 37 5.4 2.4 3.0
4. Nigeria 148 093 460 311 772 521 79 53 59 40 27.0
5. South Africa 48 577 461 948 336 692 18 38 94 193 73.0
source: Extracted from WHO report on Global Tuberculosis Control 2009.51
line with the MDG 6 objectives for TB which are:
to detect at least 70% of new sputum smear-positive TB 
cases and cure at least 85% of these cases;2 and 
to reduce TB prevalence and death rates by 50% relative 
to 1990 levels.46
The 2001-2005 South African TB Strategic Plan centred on the 
Directly Observed Treatment Short course (DOTS) strategy. 
Evaluation of the 2001-2005 National TB Programme showed 
that the TB disease burden had almost doubled from 188 695 
in 2001 to 341 165 in 2006, with an estimated HIV co-infec-
tion rate of 55%.2 Cure and completion rates remained 
below target, case holding in the intensive phase of treatment 
ranged from 1% to 4%, and 7% of patients still remained 
smear positive at the end of the intensive phase of treatment. 
Finally, sputum smear to confirm cure for a large proportion 
ÿ
ÿ
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of cases (11%) was not performed.52 Major deficiencies in the 
plan included the lack of TB and HIV integration; poor defini-
tion of roles and responsibilities; and lack of a clear monitoring 
and evaluation component (including surveillance).
One of the strengths of the TB programme is that TB is one 
of the few notifiable conditions that is being reported. While 
South Africa is one of few high burden TB countries to have 
analysed mortality using data from vital registration systems 
and mortality surveys, mortality and treatment interruption 
rates remain high. This is considered to be attributable to the 
high HIV infection rates and weak health care service delivery 
mechanisms. Importantly, improvements in reporting and 
case detection have resulted in an increase in TB notification 
rates and treatment cure rates in South Africa (Table 5). Data 
indicate heterogeneity across provinces, with published data 
in 2006 showing cure rates ranging from 53% in KwaZulu-
Natal to over 77% in the Western Cape. Before the emer-
gence of HIV, the Western Cape reported the highest rates of 
TB. However, in 2006 KwaZulu-Natal, with an antenatal HIV 
prevalence of 39.1%, exceeded the national HIV incidence 
rate, reporting a TB prevalence of 1 066 per 100 000 popula-
tion. KwaZulu-Natal also had amongst the worst National TB 
Programme (NTP) performance indicators.13
Table 5:  Case detection rate and treatment success in the 
DOTS programme for new smear-positive cases in 
South Africa 2000-2007, by percentage 
2000 2001 2002 2003 2004 2005 2006 2007
Case detection rate 63 60 71 77 75 72 77 78
Treatment success 
(2000-2006 cohorts) 66 65 68 67 70 71 74 N/A
source: Adapted from WHO Report 2009, Global Tuberculosis Control.51
The challenges faced are substantial and include increasing 
caseloads in the face of an over-burdened health infrastruc-
ture, extremely poor cure rates in some provinces, high 
mortality, high treatment interruption rates, high levels of TB-
HIV co-infection, increased levels of multi-drug resistant TB 
(MDR-TB) and the emergence of extensively drug resistant 
TB (XDR-TB). Of the high burden TB countries, South Africa 
has amongst the highest estimated costs for TB. This is due 
mainly to two reasons: the enormous cost of maintaining 
approximately 8 000 TB beds and the cost of diagnosing and 
treating drug resistant TB.52 Other challenges facing South 
Africa’s ability to meet the MDGs are high treatment inter-
ruption rates, late presentation of patients to health facilities, 
insufficient community engagement, the HIV epidemic and 
poverty. 
Despite these challenges, TB control in South Africa has 
improved somewhat in the last 10 years, albeit not enough. 
Failure to achieve the targets set by the World Health 
Assembly, the impact of HIV in fuelling TB and the problems 
with TB control in developing countries has led to a wide-
spread recognition that TB control needs to extend beyond 
the DOTS strategy into combined prevention strategies that 
target multiple antecedents of TB.13
This raises important questions about the quality of treat-
ment and follow-up, the quality of data collected and how this 
information could be used to improve treatment completion 
rates.
Multi- and extensively drug resistant TB
South Africa has made progress in diagnosing and treating 
multi- and extensively drug resistant TB (MDR- and XDR-TB) 
as reflected in the World Health Organization (WHO) indi-
cators used to assess the management of drug-resistant TB. 
By 2007, South Africa had conducted drug resistance surveil-
lance, had developed national guidelines and training mate-
rial, conducted training, initiated scaling-up of treatment, fully 
integrated the drug resistant TB programme into activities of 
the NTP and had reported MDR-TB data.52 
Decentralising drug resistant TB 
management
Of the 2 472 and 2 572 cases of MDR-TB diagnosed in 
KwaZulu-Natal laboratories in 2005 and 2006 respectively, 
only 56% in 2005 and 28% in 2006 were treated in hospital.b 
The remaining patients died while awaiting admission, were 
lost to follow-up or remained infectious in the community. 
This situation highlights the discordance between the number 
of central beds available for the management of drug resistant 
TB and the actual caseload. For this reason, the NTP has 
adopted a policy of decentralised management for MDR-TB. 
The centralised MDR-TB units (one in each province) will be 
responsible for initiating and monitoring treatment of MDR- 
and XDR-TB cases, in addition to providing support to the 
decentralised satellite MDR-TB units within that province. 
Decentralised MDR-TB units will initiate and monitor treat-
ment of only MDR-TB cases. Mobile MDR-TB clinics and 
community supporters will provide treatment and support to 
MDR-TB patients after they have been discharged from both 
the decentralised and satellite units. 
b Personal Communication: I Master, February 4, 2010.
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Challenges and opportunities 
The diversity and complexity of the HIV epidemic in each of 
the nine provinces in South Africa requires a combination of 
a multi-level and multi-component approach that includes a 
diverse set of biomedical, behavioural and structural inter-
ventions, rather than a single solution approach. Identifying 
the appropriate mix and coverage for each province remains 
challenging. 
An analysis of key HIV programme indicators demonstrates 
a shortage of information that reflects the fundamental 
dynamics of HIV in South Africa. For example, an assess-
ment of literacy on HIV life skills education has not been 
conducted. Measuring achievements in HIV education cannot 
be computed unless comparable data of this nature is avail-
able across the provinces. 
An audit of the training of health care personnel on syndromic 
STI management, as well as an audit of all health care facilities 
with respect to availability and access of patients to syndromic 
STI treatment, is non-existent.
There remains a disconnect in monitoring and evaluation 
for ART coverage between non-governmental organisations 
(NGOs), public and private sectors, resulting in an inability 
to predict numbers of patients eligible for ART, numbers 
on ART therapy, and case-holding within ART programmes. 
These aspects underscore the need for focused interventions 
to ensure system strengthening. 
Since progress cannot be measured using non-specific data 
or data that is only available for certain regions, achievements 
in terms of the NSP goals are not available for South Africa. 
This information is a priority, as it is crucial to improving HIV 
programmes across the country.
To achieve the NSP goal of reducing new HIV infections by 
50%, each province has to deal with different HIV epidemic 
dynamics in terms of AIDS deaths, the number in need of 
ART, the number on ART, the number of new HIV infections 
and, more importantly, to test and find interventions that will 
dramatically alter the course of the HIV epidemic in South 
Africa. 
Only with a highly active HIV prevention strategy, widespread 
ART coverage, counselling of new HIV infections with behav-
iour change, biomedical intervention and treatment of STIs, is 
the trajectory of the HIV epidemic likely to change and impact 
on the rate of new HIV infections. This differential provin-
cial response to the HIV and AIDS pandemics will also help 
South Africa to achieve its commitment to the Millennium 
Development Goals. 
New legislation on HIV testing by lay counsellors, revised 
ART guidelines, dispensing of antiretroviral (ARV) medica-
tion by nurses, implementation of medical male circumci-
sion programmes, and continued expansion of the ART 
programmes provide a solid and enabling context for substan-
tial strengthening of the HIV and AIDS response in South 
Africa. 
Continued effort with unprecedented partnerships, continued 
strong leadership, collective commitment and dedication is 
required to reverse the epidemic. 
Knowledge of HIV status remains an important gateway 
for treatment and prevention services. Novel strategies to 
normalise HIV at a community level and overcome fears, 
stigma and discrimination is key. Home testing in partnership 
with community structures, social mobilisation and maxim-
ising opportunities to know one’s status, e.g. during health 
facility visits, need to be proactively utilised. 
School-based interventions to promote knowledge of HIV 
status and incentivise young people to remain uninfected 
as part of the national HCT campaign could impact on the 
rates of new infections but is a strategy that has received 
little attention to date. School-based interventions need to be 
rigorously evaluated and tough decisions made on retaining 
or removing interventions impacting HIV incidence rates. 
The school setting and the role of teachers in inculcating in 
learners a sense of future through high quality educational 
services that create good career opportunities for learners 
and build self-esteem and confidence in young people to be 
socially and economically productive members of society and 
realise their full potential needs more attention. 
Teachers, as members of society, are also at risk of acquiring 
HIV infection and efforts to strengthen knowledge of HIV 
status and access to care is critically important for the survival 
of this sector that is under-skilled and under-staffed. 
Schools are first points for identifying learners who come from 
vulnerable homes where they may be without adult supervi-
sion or caring for sick parents. Schools provide an opportunity 
to link these families to social service programmes. 
Support for women-initiated biomedical interventions such 
as microbicides need to augment the current HIV prevention 
toolbox. 
Postpartum visits are a missed opportunity to retest HIV-
negative women and their partners to promote prevention, 
identify infection in the infants and initiate infants and children 
who need ARVs on treatment. Active screening for STIs and 
TB antenatally and postnatally is also missed and needs to be 
addressed.
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South Africa has adopted the Stop TB Partnership Policy of 
the three I’s (Intensified case finding, Isoniazid prophylaxis for 
latent TB and Infection control). These are in varying phases of 
implementation and have yet to be properly evaluated. It has 
been suggested that the ‘Integration of TB and HIV manage-
ment’ should be added to this list. South Africa also subscribes 
to the Stop TB Partnership that envisages newer TB drugs, 
new diagnostics and a TB vaccine by 2015.
The Starting ARV treatment at three points in TB (SAPiT) study 
findings show that in TB-HIV co-infected patients with a CD4 
cell count less than 500, the mortality rate was 56% lower 
when TB treatment was combined with ART’s in comparison 
to delaying ART until completion of TB treatment.53 This 
means that deaths can be more than halved by combining ART 
with TB treatment. The study provides compelling evidence 
for the integration of care and treatment programmes for 
both TB and AIDS. To ensure successful integration, all newly 
diagnosed TB patients in South Africa need to be offered an 
HIV test, while those who are HIV-positive need to be offered 
a CD4 count and those with a CD4 count below 500 cells 
per cubic millimetre must be offered ART in conjunction with 
TB treatment. The public health and clinical care approach 
to the joint TB and HIV epidemics has the potential to save 
lives. Given the intertwined TB and HIV epidemics, integra-
tion of HIV and TB services is critical, as well as HIV testing 
of TB patients and early initiation of TB patients on ART. 
The government policy on initiation of ARV treatment in TB 
patients at a higher CD4 count level is important, given the 
high mortality rates in TB-HIV co-infected patients.
Conclusion
South Africa’s success towards achieving MDG 6, and indeed 
all the MDGs, requires partnership and collaboration of 
an unprecedented nature. The Zuma administration has 
provided unequivocal political leadership and commitment. 
International partners provided substantial support during the 
AIDS denialism era in very creative and novel ways to make 
treatment a reality. Global solidarity and local social move-
ments have played important catalytic roles in getting the 
country to this positive point in response to the epidemic. 
Scientists, health-care workers and other professionals have 
been key to generating new knowledge and implementation. 
These partnerships and commitments must continue around 
a much more focused, priority-based agenda to make the 
MDGs a reality and sustain the gains we are making in HIV and 
AIDS and in TB and expand the impacts to other MDGs and 
other health challenges. South Africa cannot afford compla-
cency or a loss of momentum. 
South Africa’s continued collective effort is essential and 
central to success and, most importantly, will benefit those 
most vulnerable and in need.
There remain numerous challenges, none of which are 
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